Inside the 10th Annual Alzheimer’s Drug Discovery Foundation Luncheon
Inside the 10th Annual Alzheimer’s Drug Discovery Foundation Luncheon
On November 1, The Alzheimer’s Drug Discovery Foundation marked 10 years of its Annual Fall Symposium and Luncheon “Hope on the Horizon,” having raised nearly $10 million for Alzheimer’s research over the past decade. This year’s event welcomed over 400 guests and raised $1.2 million for Alzheimer’s research. Nine-time Emmy Award winner and longtime ADDF board member Paula Zahn returned to host the inspirational event and welcomed guests to the luncheon.
ADDF Co-Founder and Co-Chairman Ronald S. Lauder noted presented the Charles Evans Award to Pamela Newman, CEO of PJN Strategies, for her support of Alzheimer’s research. “Pamela truly embodies the altruistic essence of this award,” said Lauder. “Like Charles Evans, who this award is named in memory of, Pamela’s determination, advocacy and enthusiasm derive from her personal connection to the disease.” Founded in 1998 by Leonard A. and Ronald S. Lauder, the ADFF is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer's disease
The event honored those who have helped raise $10M for Alzheimer's research
